{"id":"https://openalex.org/W22396515","doi":"https://doi.org/10.1016/j.eururo.2003.12.010","title":"Effect of Prophylactic Treatment with Intravesical Epirubicin on Recurrence of Superficial Bladder Cancer\u2014The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG):","display_name":"Effect of Prophylactic Treatment with Intravesical Epirubicin on Recurrence of Superficial Bladder Cancer\u2014The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG):","publication_year":2004,"publication_date":"2004-01-13","ids":{"openalex":"https://openalex.org/W22396515","doi":"https://doi.org/10.1016/j.eururo.2003.12.010","mag":"22396515","pmid":"https://pubmed.ncbi.nlm.nih.gov/15082202"},"language":"en","primary_location":{"id":"doi:10.1016/j.eururo.2003.12.010","doi":"https://doi.org/10.1016/j.eururo.2003.12.010","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.eururo.2003.12.010","pdf_url":null,"source":{"id":"https://openalex.org/S96871409","display_name":"European Urology","issn_l":"0302-2838","issn":["0302-2838","1421-993X","1873-7560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Urology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108458625","display_name":"Masao Kuroda","orcid":"https://orcid.org/0009-0003-3605-0851","observed_orcids":["https://orcid.org/0009-0003-3605-0851"]},"institutions":[{"id":"https://openalex.org/I4210164826","display_name":"Nippon Life Hospital","ror":"https://ror.org/05kp9zx42","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210164826"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masao Kuroda","raw_affiliation_strings":["Department of Urology, Nissay Hospital, 6-3-8 Tachiuribor, Nishi-ku, Osaka 550-0012, Japan. Takahiro.yamaguchi@japan.pfizer.com","Department of Urology, Nissay Hospital, 6-3-8 Tachiuribor, Nishi-ku, Osaka 550-0012, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Nissay Hospital, 6-3-8 Tachiuribor, Nishi-ku, Osaka 550-0012, Japan. Takahiro.yamaguchi@japan.pfizer.com","institution_ids":["https://openalex.org/I4210164826"]},{"raw_affiliation_string":"Department of Urology, Nissay Hospital, 6-3-8 Tachiuribor, Nishi-ku, Osaka 550-0012, Japan","institution_ids":["https://openalex.org/I4210164826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109600341","display_name":"Tadao Niijima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405284033","display_name":"Tokyo Takanawa Hospital","ror":"https://ror.org/02skza330","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132540","https://openalex.org/I4405284033"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadao Niijima","raw_affiliation_strings":["Tokyo Takanawa Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo Takanawa Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405284033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110964334","display_name":"Toshihiko Kotake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151107","display_name":"Osaka International Cancer Institute","ror":"https://ror.org/05xvwhv53","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210151107","https://openalex.org/I4405282797"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshihiko Kotake","raw_affiliation_strings":["Osaka Medical Center for Cancer, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Osaka Medical Center for Cancer, Osaka, Japan","institution_ids":["https://openalex.org/I4210151107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112014088","display_name":"Hideyuki Akaza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146399215","display_name":"University of Tsukuba","ror":"https://ror.org/02956yf07","country_code":"JP","type":"education","lineage":["https://openalex.org/I146399215"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideyuki Akaza","raw_affiliation_strings":["University of Tsukuba, Tsukuba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tsukuba, Tsukuba, Japan","institution_ids":["https://openalex.org/I146399215"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111165670","display_name":"Shiro Hinotsu","orcid":"https://orcid.org/0009-0001-3111-695X","observed_orcids":["https://orcid.org/0009-0001-3111-695X"]},"institutions":[{"id":"https://openalex.org/I146399215","display_name":"University of Tsukuba","ror":"https://ror.org/02956yf07","country_code":"JP","type":"education","lineage":["https://openalex.org/I146399215"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shiro Hinotsu","raw_affiliation_strings":["University of Tsukuba, Tsukuba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tsukuba, Tsukuba, Japan","institution_ids":["https://openalex.org/I146399215"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5108458625"],"corresponding_institution_ids":["https://openalex.org/I4210164826"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":null,"fwci":1.79,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.83285209,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"45","issue":"5","first_page":"600","last_page":"605"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12695","display_name":"Urinary and Genital Oncology Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.8569999933242798},{"id":"https://openalex.org/keywords/intravesical-chemotherapy","display_name":"intravesical chemotherapy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/superficial-bladder-cancer","display_name":"superficial bladder cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/bladder-cancer-recurrence","display_name":"bladder cancer recurrence","score":0.7099999785423279},{"id":"https://openalex.org/keywords/prophylaxis","display_name":"prophylaxis","score":0.7670000195503235},{"id":"https://openalex.org/keywords/drug-concentration","display_name":"drug concentration","score":0.6240000128746033},{"id":"https://openalex.org/keywords/recurrence-free-rate","display_name":"recurrence-free rate","score":0.6430000066757202},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8040000200271606},{"id":"https://openalex.org/keywords/urinary-frequency","display_name":"urinary frequency","score":0.949999988079071},{"id":"https://openalex.org/keywords/transurethral-resection-of-bladder-tumor","display_name":"transurethral resection of bladder tumor","score":0.8289999961853027},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9551788568496704},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.8681813478469849},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.7456985116004944},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5881664752960205},{"id":"https://openalex.org/C175768497","wikidata":"https://www.wikidata.org/wiki/Q105726","display_name":"Urination","level":3,"score":0.5619046688079834},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5614736080169678},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.49625927209854126},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.426497220993042},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3816072642803192},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3697590231895447},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.1609799861907959},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.13624322414398193}],"mesh":[{"descriptor_ui":"D000283","descriptor_name":"Administration, Intravesical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D002295","descriptor_name":"Carcinoma, Transitional Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002295","descriptor_name":"Carcinoma, Transitional Cell","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.eururo.2003.12.010","doi":"https://doi.org/10.1016/j.eururo.2003.12.010","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.eururo.2003.12.010","pdf_url":null,"source":{"id":"https://openalex.org/S96871409","display_name":"European Urology","issn_l":"0302-2838","issn":["0302-2838","1421-993X","1873-7560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Urology","raw_type":"journal-article"},{"id":"pmid:15082202","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15082202","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European urology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1968838861","https://openalex.org/W2015807534","https://openalex.org/W2409563682","https://openalex.org/W2417407414","https://openalex.org/W2885877668","https://openalex.org/W4365787053"],"related_works":["https://openalex.org/W2463612468","https://openalex.org/W1983956345","https://openalex.org/W2010069207","https://openalex.org/W2031011443","https://openalex.org/W2393665185","https://openalex.org/W7025925992","https://openalex.org/W2382060774","https://openalex.org/W2371425178","https://openalex.org/W2462163988","https://openalex.org/W3150203238"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}